Xolair 150 MG/1.2 ML powder VLS

Ended Awarded

Contract number
SPE2DB23FM8HX
Awardee
Awarding agency
Obligated
$27,853

Award facts

Contract value 100% obligated
$27,853.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from July 25, 2023 through August 15, 2023, with all work to be performed in Park Ridge, Illinois. The DLA supports Department of Defense procurement and supply chain management, and this small contract will deliver an asthma medication to likely support military treatment facilities in the region. No subcontractors or set aside designations were identified.

Quick answers

Who was awarded contract SPE2DB23FM8HX?

SPE2DB23FM8HX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2023.

How much is contract SPE2DB23FM8HX worth?

The government has obligated $27,853 on SPE2DB23FM8HX.

Is contract SPE2DB23FM8HX an order under another contract?

Yes. SPE2DB23FM8HX is a delivery order under SPE2DB22D9151, an indefinite delivery contract.

Was contract SPE2DB23FM8HX competed?

The extent of competition for SPE2DB23FM8HX was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award